药品套利：平衡国际处方药市场中的可及性与创新 - Suppr

Suppr

超能文献

Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.

作者信息

Outterson Kevin

机构信息

West Virginia University College of Law, USA.

出版信息

Yale J Health Policy Law Ethics. 2005 Winter;5(1):193-291.

PMID:15742578

Abstract

摘要

相似文献

Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.

Yale J Health Policy Law Ethics. 2005 Winter;5(1):193-291.

Pills, patents, and power: state creation of gray markets as a limit on patent rights.

Fla J Int Law. 2002 Spring;14(2):217-60.

Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.

Houst J Int Law. 2002;24(2):227-78.

The effect of drug reimportation on managed care pharmacy.

Manag Care Interface. 2003 Jul;16(7):41-2.

Introduction: pharmaceutical innovation: law & the public's health.

J Law Med Ethics. 2009 Summer;37(2):173-5. doi: 10.1111/j.1748-720X.2009.00363.x.

Rights, patents, markets and the global AIDS pandemic.

Fla J Int Law. 2002 Spring;14(2):261-352.

Trips and public health: solutions for ensuring global access to essential AIDS medication in the wake of the Paragraph 6 Waiver.

J Contemp Health Law Policy. 2008 Fall;25(1):142-65.

Prescription drug benefits for seniors and public/private collaboration.

Beginnings. 2002 May-Jun;22(3):11.

Eliminating innovation: how price controls limit access.

J Leg Med. 2011 Jan;32(1):115-28. doi: 10.1080/01947648.2011.550833.

Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry?

JAMA. 2020 Mar 3;323(9):821-822. doi: 10.1001/jama.2019.22357.

引用本文的文献

Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping review.

J Med Access. 2024 Mar 11;8:27550834241236598. doi: 10.1177/27550834241236598. eCollection 2024 Jan-Dec.

Impact of the European Union on access to medicines in low- and middle-income countries: A scoping review.

Lancet Reg Health Eur. 2021 Oct 7;9:100219. doi: 10.1016/j.lanepe.2021.100219. eCollection 2021 Oct.

Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020.

Clin Infect Dis. 2022 Apr 9;74(7):1183-1190. doi: 10.1093/cid/ciab612.

The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value.

PLoS One. 2021 Jan 11;16(1):e0244722. doi: 10.1371/journal.pone.0244722. eCollection 2021.

Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues.

Pharmacoeconomics. 2018 Dec;36(12):1395-1405. doi: 10.1007/s40273-018-0696-4.

Sustainable vaccine development: a vaccine manufacturer's perspective.

Curr Opin Immunol. 2018 Aug;53:111-118. doi: 10.1016/j.coi.2018.04.019. Epub 2018 May 8.

Challenges for nationwide vaccine delivery in African countries.

Int J Health Econ Manag. 2018 Jun;18(2):197-219. doi: 10.1007/s10754-017-9229-5. Epub 2017 Oct 19.

Enhancing medicine price transparency through price information mechanisms.

Global Health. 2014 May 8;10:34. doi: 10.1186/1744-8603-10-34.

The silent epidemic of exclusive university licensing policies on compounds for neglected diseases and beyond.

PLoS Negl Trop Dis. 2010 Mar 30;4(3):e570. doi: 10.1371/journal.pntd.0000570.

Closing the access gap for health innovations: an open licensing proposal for universities.

Global Health. 2007 Feb 1;3:1. doi: 10.1186/1744-8603-3-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验